Trial Profile
A placebo-controlled clinical pharmacology study evaluated the effects of telbivudine on cardiac safety
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2015
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- 14 Jan 2015 New trial record